subscribeSubscribe
Eyenovia Updates on Mydcombi„ & Clobetasol Ophthalmic Suspension

Eyenovia Updates on Mydcombi„ & Clobetasol Ophthalmic Suspension
GLOBENEWSWIRE
25 Apr 2024
Share Share
US FDA approves Eyenovia`s eye drug, Formosa Pharma says

US FDA approves Eyenovia`s eye drug, Formosa Pharma says
REUTERS
05 Mar 2024
Share Share
Formosa Pharmaceuticals Announces Licensing Agreement with Cristália

Formosa Pharmaceuticals Announces Licensing Agreement with Cristália
PR NEWSWIRE
26 Jan 2024
Share Share
Zhejiang Yongtai`s Generic Clobetasol Propionate Receives Approval in the U.S.

Zhejiang Yongtai`s Generic Clobetasol Propionate Receives Approval in the U.S.
FDA
28 Dec 2023
Share Share
Enforcement Report - Week of June 7, 2023

Enforcement Report - Week of June 7, 2023
FDA
07 Jun 2023
Share Share
Enforcement Report - Week of February 1, 2023

Enforcement Report - Week of February 1, 2023
FDA
01 Feb 2023
Share Share
Salvat Laboratories Submits NDA to FDA

Salvat Laboratories Submits NDA to FDA
CONTRACTPHARMA
31 Oct 2022
Share Share
Enforcement Report - Week of April 20, 2022

Enforcement Report - Week of April 20, 2022
FDA
20 Apr 2022
Share Share
Enforcement Report - Week of March 30, 2022

Enforcement Report - Week of March 30, 2022
FDA
30 Mar 2022
Share Share
Solaris Pharma`s Generic Clobetasol Propionate Receives Approval in the U.S.

Solaris Pharma`s Generic Clobetasol Propionate Receives Approval in the U.S.
FDA
17 Feb 2022
Share Share